These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21207078)

  • 21. The language profile of progressive supranuclear palsy.
    Catricalà E; Boschi V; Cuoco S; Galiano F; Picillo M; Gobbi E; Miozzo A; Chesi C; Esposito V; Santangelo G; Pellecchia MT; Borsa VM; Barone P; Garrard P; Iannaccone S; Cappa SF
    Cortex; 2019 Jun; 115():294-308. PubMed ID: 30884283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Steiger R; Wildauer M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
    Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
    Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterizing gait and exploring neuro-morphometry in patients with PSP-Richardson's syndrome and vascular parkinsonism.
    Chatterjee K; Paul S; Banerjee R; Choudhury S; Tiwari M; Basu P; Kumar H
    Parkinsonism Relat Disord; 2023 Aug; 113():105483. PubMed ID: 37354829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid.
    Boman A; Svensson S; Boxer A; Rojas JC; Seeley WW; Karydas A; Miller B; Kågedal K; Svenningsson P
    J Parkinsons Dis; 2016 Apr; 6(2):307-15. PubMed ID: 27061067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy.
    Schirinzi T; Sancesario GM; Di Lazzaro G; Scalise S; Colona VL; Imbriani P; Mercuri NB; Bernardini S; Lang AE; Pisani A
    J Neural Transm (Vienna); 2018 Sep; 125(9):1373-1379. PubMed ID: 29948175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic Resonance Parkinsonism Index for evaluating disease progression rate in progressive supranuclear palsy: A longitudinal 2-year study.
    Quattrone A; Morelli M; Quattrone A; Vescio B; Nigro S; Arabia G; Nisticò R; Novellino F; Salsone M; Arcuri P; Luca A; Mazzuca A; Alessio C; Rocca F; Caracciolo M
    Parkinsonism Relat Disord; 2020 Mar; 72():1-6. PubMed ID: 32036297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
    Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
    Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progressive supranuclear palsy.
    Giagkou N; Höglinger GU; Stamelou M
    Int Rev Neurobiol; 2019; 149():49-86. PubMed ID: 31779824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Commentary on: Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism, by D. Williams, R. de Silva, D. Paviour, et al. (Brain-2004-01045.R1).
    Burn DJ
    Brain; 2005 Jun; 128(Pt 6):1235-6. PubMed ID: 15900030
    [No Abstract]   [Full Text] [Related]  

  • 31. Differentiating between common PSP phenotypes using structural MRI: a machine learning study.
    Quattrone A; Sarica A; Buonocore J; Morelli M; Bianco MG; Calomino C; Aracri F; De Maria M; Vescio B; Vaccaro MG; Quattrone A
    J Neurol; 2023 Nov; 270(11):5502-5515. PubMed ID: 37507502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropsychological assessment could distinguish among different clinical phenotypes of progressive supranuclear palsy: A Machine Learning approach.
    Vaccaro MG; Sarica A; Quattrone A; Chiriaco C; Salsone M; Morelli M; Quattrone A
    J Neuropsychol; 2021 Sep; 15(3):301-318. PubMed ID: 33231380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study.
    Seckin ZI; Duffy JR; Strand EA; Clark HM; Utianski RL; Machulda MM; Botha H; Ali F; Thu Pham NT; Lowe VJ; Whitwell JL; Josephs KA
    Parkinsonism Relat Disord; 2020 Dec; 81():34-40. PubMed ID: 33045651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Midbrain atrophy in patients with presymptomatic progressive supranuclear palsy-Richardson's syndrome.
    Ahn JH; Kim M; Kim JS; Youn J; Jang W; Oh E; Lee PH; Koh SB; Ahn TB; Cho JW
    Parkinsonism Relat Disord; 2019 Sep; 66():80-86. PubMed ID: 31307918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Automated MRI Classification in Progressive Supranuclear Palsy: A Large International Cohort Study.
    Nigro S; Antonini A; Vaillancourt DE; Seppi K; Ceravolo R; Strafella AP; Augimeri A; Quattrone A; Morelli M; Weis L; Fiorenzato E; Biundo R; Burciu RG; Krismer F; McFarland NR; Mueller C; Gizewski ER; Cosottini M; Del Prete E; Mazzucchi S; Quattrone A
    Mov Disord; 2020 Jun; 35(6):976-983. PubMed ID: 32092195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are PSP patients included in clinical trials representative of the general PSP population?
    Mariani LL; Guimarães-Costa R; Grabli D; Le Toullec B; Cormier-Dequaire F; Degos B; Dubois B; Vidailhet M; Lacomblez L; Corvol JC
    Parkinsonism Relat Disord; 2019 Sep; 66():202-206. PubMed ID: 31303434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic Spectrum of Progressive Supranuclear Palsy: Clinical Study and Apolipoprotein E Effect.
    Nasri A; Sghaier I; Neji A; Gharbi A; Abida Y; Mrabet S; Gargouri A; Djebara MB; Kacem I; Gouider R
    J Mov Disord; 2024 Apr; 17(2):158-170. PubMed ID: 38290492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive supranuclear palsy.
    Boeve BF
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S192-4. PubMed ID: 22166432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP-parkinsonism: a VBM-DARTEL study.
    Agosta F; Kostić VS; Galantucci S; Mesaros S; Svetel M; Pagani E; Stefanova E; Filippi M
    Eur J Neurosci; 2010 Aug; 32(4):640-7. PubMed ID: 20597976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Parkinson's disease" on the way to progressive supranuclear palsy: a review on PSP-parkinsonism.
    Necpál J; Borsek M; Jeleňová B
    Neurol Sci; 2021 Dec; 42(12):4927-4936. PubMed ID: 34532773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.